Description:
The economics of biotech have changed.
Capital is more expensive than it was a few years ago. Reimbursement is entering the conversation earlier. The newest therapies are also the hardest to manufacture and pay for. And AI is starting to move from promise into practical use across the industry.
On this episode of The Orange T, Stephen M. Perry talks with biotech entrepreneur and investor Audrey Greenberg about what that shift means for the companies building the next generation of therapies.
They discuss three forces reshaping the industry:
- Why scientific innovation alone is no longer enough to make a therapy commercially successful
- How manufacturing costs and reimbursement pressure are reshaping advanced therapies
- Why investors are becoming more sophisticated about risk and return
Greenberg also shares what she is seeing as a venture partner at Mayo Clinic, including how AI is being used to analyze complex patient data, support clinical decisions and potentially change how risk is financed in early-stage drug development..
About Audrey Greenberg
Audrey Greenberg is a biotech entrepreneur, investor and venture partner at Mayo Clinic. She previously co-founded and scaled Center for Breakthrough Medicines, a contract development and manufacturing organization focused on cell and gene therapies.
About The Orange T
The Orange T explores what it means to be a T-shaped professional: developing deep expertise while building the breadth needed to connect ideas, disciplines and people.
🎧 Subscribe to The Orange T for conversations about biotechnology, healthcare, investment, innovation and the forces shaping the future of life sciences.
What is The Orange T?
What does it mean to be a T shaped professional, broad in perspective, deep in expertise, and abreast of innovation.
Hosted by Stephen M. Perry, founder and CEO of Kymanox, we unpack ideas that shape the future, build exceptional teams, and create lasting impact. From thought leadership on performance and wellness to insights into modern healthcare, this is your space to think holistically and grow intentionally. Just like the T Shaped professionals who make Kymanox a leader in the life science industry.